Coronavirus Update - 21st May 2020

We understand our customers concerns relating to the spread of COVID-19 and would like to assure you that we are located in one of the least affected areas of the UK and are open for business as usual.

We can confirm that we have complied with the government's guidance on managing the risk of COVID-19.

Download the certificate here

---

Arcinova Releases Latest Case Study - Capsule Product Manufacturing

The challenge - Accelerate first-in-human and Phase II trials for an oral dosage form intended for treatment of CNS disorders. A fully integrated approach was required, to include drug substance manufacture, formulation development, GMP clinical manufacture, IMP packaging, labelling and assembly, distribution, and compilation of a CMC dossier.

Find out more about how we solved the issue here